Evidence map›Paper›PMID 15111318›Full record

ArticleThe American journal of pathology2004

Anti-human Olig2 antibody as a useful immunohistochemical marker of normal oligodendrocytes and gliomas.

Hideaki Yokoo, Sumihito Nobusawa, Hirohide Takebayashi, Kazuhiro Ikenaka, Koji Isoda, Makoto Kamiya, Atsushi Sasaki, Junko Hirato, Yoichi Nakazato

Open access · bronzeAbstract read
In one paragraph

Article in The American journal of pathology, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 52 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
52citing papers in PubMed, 1 pooled it
4.9field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

52 citing papers in PubMed, 1 synthesis or guideline pooled it, 140 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. GEARBOCS: An Adeno Associated Virus Tool forbioRxiv : the preprint server for biology · 2024
    Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Hideaki YokooDepartment of Pathology, Gunma University Graduate School of Medicine, Maebashi, Japan. yokoo@med.gunma-u.ac.jp
Sumihito Nobusawa
Hirohide Takebayashi
Kazuhiro Ikenaka
Koji Isoda
Makoto Kamiya
Atsushi Sasaki
Junko Hirato
Yoichi Nakazato
Gunma University · JPNational Institute for Physiological Sciences · JPNational Institutes of Natural Sciences · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Olig2 is a recently identified transcription factor involved in the phenotype definition of cells in the oligodendroglial lineage. The expression of Olig2 transcript has been demonstrated in human oligodendroglial tumors, although the protein expression has not been studied extensively. We developed a polyclonal antibody to human Olig2 and analyzed it immunohistochemically. The antibody depicted a single distinct band of predicted molecular weight by Western blotting, and did not cross-react with human Olig1. In normal human brain tissue, the nuclei of oligodendrocytes of interfascicular, perivascular, and perineuronal disposition were clearly labeled by the antibody. Similarly, the nuclei of oligodendroglial tumors were labeled. There was no apparent correlation between the staining intensity and histological grade. Astrocytic components within the tumors were generally less or not stained. Astrocytic tumors were also positive with the Olig2 antiserum to a lesser extent, and the difference between oligodendroglial and astrocytic tumors was demonstrated by a statistical analysis. Olig2 and glial fibrillary acidic protein were expressed in a mutually exclusive manner, and Olig2 expression was cell-cycle related. Neither central neurocytoma nor schwannoma cases were stained. Our antibody was demonstrated to be useful in recognizing normal oligodendrocytes on paraffin sections, and applicable in diagnosis of some brain tumors.

Indexed as

AnimalsAntibodiesBasic Helix-Loop-Helix ProteinsBlotting, WesternBrainCell CycleCell LineageCell NucleusGlial Fibrillary Acidic ProteinGliomaHumansImmunohistochemistryMiceNerve Tissue ProteinsNIH 3T3 CellsOligodendrocyte Transcription Factor 2AntibodiesBasic Helix-Loop-Helix ProteinsGlial Fibrillary Acidic ProteinNerve Tissue ProteinsOLIG2 protein, humanOlig2 protein, mouseOligodendrocyte Transcription Factor 2Paraffin

Identifiers

PMID15111318
PMCPMC1615653
OpenAlexW2035084050

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.